Cargando…
Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components
BACKGROUND: The tumor cell lysate-pulsed, dendritic cell (DC)-based cancer vaccine approaches are being actively evaluated for application to cancer immunotherapy, hopefully at a personalized medicine base. There is apparently an emerging technical problem however, the lack of highly efficacious pot...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582891/ https://www.ncbi.nlm.nih.gov/pubmed/26403780 http://dx.doi.org/10.1186/s12943-015-0435-9 |